24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
29/09/2016
Barcelona, a Friendly Ecosystem for Start-Ups
22/09/2016
Barcelona, capital of particle accelerators science and technology
15/09/2016
Tech Companies With More Than $1 Million Raised: Barcelona Ranks 5th In Europe
09/09/2016
UB and UAB Universities Stand out in Spain According to Main International Rankings
31/08/2016
New CaixaBank's Data Center Implementation Completed In Barcelona Synchrotron Park
25/08/2016
Barcelona, 4th most creative city in the world